Cook Medical Flexor Check-Flo and Tuohy-Borst Side-Arm Introducers

2021 ◽  
Vol 51 (4) ◽  
pp. 25-27
Keyword(s):  
Vascular ◽  
2014 ◽  
Vol 23 (2) ◽  
pp. 161-164
Author(s):  
Michele Piazza ◽  
Mario Lupia ◽  
Franco Grego ◽  
Michele Antonello

The technique is demonstrated in a 78-year-old man; the preoperative CT angiogram showed a descending thoracic aorta ulcer of 5.9 cm in maximum diameter and 3.8 cm longitudinal extension. A ZTEG-2P-36-127-PF (Cook Medical) single tubular endograft was planned to be deployed. From the preoperative CT angiogram we planned to land 4.7 cm above the midline of the descending thoracic aorta ulcer and 8.0 cm below. In the operating room, under radioscopic vision the centre of the transesophageal echography probe was used as marker to identify the correspondent midline of the descending thoracic aorta ulcer and a centimeter-sized pigtail catheter in the aorta was used to calculate the desired length above and below the ulcer midline. The endograft was introduced and placed in the desired position compared to the transesophageal echography probe and the catheter; under transesophageal echography vision the graft was finally deployed. The CT angiogram at 1 month showed the correct endograft position, descending thoracic aorta ulcer exclusion with no signs of endoleak. In selected cases, this method allows planning in advance safe stent graft positioning and deployment totally assisted by transesophageal echography, with no risk of periprocedural contrast-related renal failure and reduced radiation exposure for the patient and operators.


2021 ◽  
Author(s):  
Steven F Mullen

Abstract STUDY QUESTION What factors associated with embryo culture techniques contribute to the rate of medium osmolality change over time in an embryo culture incubator without added humidity? SUMMARY ANSWER The surface area-to-volume ratio of culture medium (surface area of the medium exposed to an oil overlay), as well as the density and height of the overlaying oil, all interact in a quantitative way to affect the osmolality rise over time. WHAT IS KNOWN ALREADY Factors such as medium volume, different oil types, and associated properties, individually, can affect osmolality change during non-humidified incubation. STUDY DESIGN, SIZE, DURATION Several experimental designs were used, including simple single-factor completely randomized designs, as well as a multi-factor response surface design. Randomization was performed at one or more levels for each experiment. Osmolality measurements were performed over 7 days, with up to 8 independent osmolality measurements performed per treatment group over that time. For the multi-factor study, 107 independent combinations of factor levels were assessed to develop the mathematical model. PARTICIPANTS/MATERIALS, SETTING, METHODS This study was conducted in a research laboratory setting. Commercially available embryo culture medium and oil was used. A MINC incubator without water for humidification was used for the incubation. Osmolality was measured with a vapor pressure osmometer after calibration. Viscometry and density were conducted using a rheometer, and volumetric flasks with an analytical balance, respectively. Data analyses were conducted with several commercially available software programs. MAIN RESULTS AND THE ROLE OF CHANCE Preliminary experiments showed that the surface area-to-volume ratio of the culture medium, oil density, and oil thickness above the medium all contributed significantly (P < 0.05) to the rise in osmolality. A multi-factor experiment showed that a combination of these variables, in the form of a truncated cubic polynomial, was able to predict the rise in osmolality, with these three variables interacting in the model (P < 0.05). Repeatability, as measured by the response of identical treatments performed independently, was high, with osmolality values being ± 2 of the average in most instances. In the final mathematical model, the terms of the equation were significant predictors of the outcome, with all P-values being significant, and only one P-value > 0.0001. LIMITATIONS, REASONS FOR CAUTION Although the range of values for the variables were selected to encompass values that are expected to be encountered in usual embryo culture conditions, variables outside of the range used may not result in accurate model predictions. Although the use of a single incubator type and medium type is not expected to affect the conclusions, that remains an uncertainty. WIDER IMPLICATIONS OF THE FINDINGS Using this predictive model will help to determine if one should be cautious in using a specific system and will provide guidance on how a system may be modified to provide improved stability during embryo culture. STUDY FUNDING/COMPETING INTEREST(S) This study was funded by Cook Medical. The author is a Team Lead and Senior Scientist at Cook Medical. The author has no other conflicts of interest to declare TRIAL REGISTRATION NUMBER N/A.


Author(s):  
S. Lowell Kahn

Catheterization of the contralateral gate during endovascular aortic aneurysm repair is typically of little difficulty. However, on occasion it proves challenging. With the exception of grafts such as Nellix (Endologix Inc., Irvine, CA), which utilizes parallel stents with polymer endobags, and those that employ a unibody concept, such as the AFX (Endologix Inc., Irvine, CA), all modular grafts require this step. A difficult catheterization can often be facilitated by using different catheters, such as the Cobra, Van Schie (Cook Medical Inc., Bloomington, IN), or Sos (AngioDynamics Inc., Latham, NY) designs. Alternatively, a wire advanced up and over through the contralateral gate from the ipsilateral side can be snared allowing catheterization of the gate. This chapter describes a simple alternative buddy wire technique that facilitates rapid contralateral gate catheterization.


Author(s):  
S. Lowell Kahn

Catheterization of the contralateral gate on the main body of aortic stent grafts is an important step of the endovascular aneurysm repair procedure. This step can be readily accomplished with appropriate pre- and intraprocedural planning. In cases in which the catheterization is challenging, several techniques can be utilized to overcome this difficulty. A Glidewire (Terumo Medical) together with a variety of catheters can be employed, most commonly either a hockey stick (e.g., Berenstein (AngioDynamics Inc., Latham, NY) and Kumpe (Cook Medical Inc., Bloomington, IN)) or reverse curve (e.g., Sos 1/2, Cook Medical Inc., Bloomington, IN) configuration. Occasionally, other catheters, such as a Van Schie (Cook Medical Inc., Bloomington, IN), may be useful when the gate is located away from the end of the contralateral sheath. This chapter delineates the Turret technique for rapid gate catheterization.


2020 ◽  
Vol 58 (10) ◽  
pp. 939-944
Author(s):  
Holger H. Lutz ◽  
Christian Trautwein ◽  
Jens J.W. Tischendorf

Zusammenfassung Hintergrund Bei Vorliegen einer Stenose der Gallenwege kann die histologische Charakterisierung für die weiteren Therapiemaßnahmen entscheidend sein. Nicht bei jedem Patienten ist ein Zugang zur Stenose mittels endoskopischer retrograder Cholangiografie (ERC) möglich. In diesen Fällen kann eine perkutane transhepatische Cholangiodrainage (PTCD) hilfreich sein. Die optimale Technik und die diagnostische Wertigkeit einer Biopsie im Rahmen der PTCD sind allerdings nicht hinreichend evaluiert. Methoden In einem Zeitraum von 24 Monaten wurde nach einer Trainingsphase von 10 Patienten bei insgesamt 30 Patienten mit Stenose der Gallenwege und fehlender adäquater Ableitungsmöglichkeit mittels ERC eine PTCD angelegt. Dabei wurde die Stenose mit einem Draht passiert und anschließend die gezielte Zangenbiopsie der Stenose unter Zuhilfenahme einer drahtgeführten Einführschleuse (7-Fr-Innendurchmesser) in einer „Cross and Push“-Technik (Transluminal Biliary Biopsy Forceps Set, Cook Medical™) durchgeführt. Das Ergebnis der histologischen Begutachtung der Biopsien wurde anschließend mit der definitiven Diagnose korreliert. Die Nachbeobachtungszeit betrug 18 Monate. Ergebnis Von insgesamt 30 Patienten wiesen 22 (73 %) eine maligne Stenose (10 Gallenwegneoplasien, 12 nichtbiliäre Karzinome/Metastasen/Lymphome) auf. Acht (27 %) der 30 Patienten hatten eine benigne Stenose. Bei allen 30 Patienten erbrachte die Biopsien ausreichendes Material zur histologischen Begutachtung. Die Subgruppenanalyse wurde für Gallenwegtumoren und nichtbiliäre Tumoren durchgeführt. Dabei wurde in 8 von 10 Patienten mit einer Gallenwegneoplasie die Stenose auch histologisch als maligne klassifiziert (Sensitivität 80 %), während dies nur in 8 von 12 nichtbiliären Tumoren gelang (Sensitivität 66,6 %, Unterschied n. s., p = 0,0577). Bei allen Patienten mit benigner Stenose zeigte sich auch in der histologischen Beurteilung der Biopsien ein benigner Befund (Spezifität 100 %). Interventionsbedingte Komplikationen traten nicht auf. Schlussfolgerung In dieser prospektiven Kohortenstudie weist das perkutane transduktale Biopsieset eine relative hohe diagnostische Genauigkeit zur Abklärung einer unklaren Gallengangsstenose – insbesondere bei biliären Prozessen – auf. Auch aufgrund der teils schwierigen anderweitigen Histologiegewinnung bei malignen Gallenwegprozessen ergänzt die „Cross and Push“-Biopsie das Spektrum der diagnostischen Verfahren.


Vascular ◽  
2012 ◽  
Vol 20 (2) ◽  
pp. 113-117 ◽  
Author(s):  
Jeffrey Jim ◽  
Andres Fajardo ◽  
Patrick J Geraghty ◽  
Luis A Sanchez

The purpose of this case report is to describe the use of thoracic endografts in endovascular repair of abdominal aortic aneurysms (AAAs) with large-diameter aortic necks. We present four patients who underwent elective repair of AAAs. Preoperative imaging demonstrated all to have large aortic necks (35–37 mm) precluding treatment with standard abdominal aortic devices. All underwent endovascular treatment, which included the use of a Zenith TX2 endograft (Cook Medical Incorporated, Bloomington, IN, USA) as a proximal aortic cuff. There was 100% technical success. One patient developed gastrointestinal bleeding and a myocardial infarction. All were subsequently discharged home. On follow-up, there was one aneurysm-related death at three months. The remaining three patients are alive at a mean of 25.7 months after their operation. In conclusion, large proximal aortic necks preclude endovascular treatment with standard abdominal endograft components. The use of a thoracic endograft as a proximal aortic cuff is a feasible technique for patients unable to tolerate open aortic reconstruction.


2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
T Pepper ◽  
R Karia ◽  
F Ryba

Abstract Aim The aim of this retrospective case series was to investigate the influence of sialolith size on the potential for endoscopic stone removal. Method The records of 52 patients who underwent salivary endoscopy between September 2018 and February 2020 were reviewed. Included cases presented with at least one symptomatic major salivary gland, and sonographic or radiographic evidence of stone disease. Results A total of 25 patients (48%) and 27 stones were identified. These patients had a mean age of 45.2 years (range 16–72); 52% were female. Most cases (19/25) involved the submandibular gland, with a virtually even division between left and right sides. The overall success rate of sialendoscopic retrieval was 23/27 (85%), with 17/27 stones removed intact and 6/27 undergoing fragmentation with an intraoral salivary pneumatic lithotripter (Cook Medical). Median (sonographic) stone size in the largest dimension for those stones removed intact was 4mm (range 3-12mm), while for those undergoing fragmentation it was 7mm (range 3-11mm). Ultrasound provided an accurate assessment of stone size in most cases, but underestimated diameter by an average of 1mm in 6/27 cases, and overestimated size by 1mm in a single case. Conclusions Sialendoscopic stone retrieval is a minimally invasive and effective treatment for sialolithiasis. It is possible to remove most stones using a basket, with intraoral lithotripsy employed for larger stones. Ultrasound is a reliable diagnostic tool for predicting stone size but may underestimate size in a small proportion of cases.


2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S448-S448
Author(s):  
Bahgat Gerges ◽  
Joel Rosenblatt ◽  
Y-Lan Truong ◽  
Ruth Reitzel ◽  
Ray Y Hachem ◽  
...  

Abstract Background Central Line Associated Bloodstream Infections (CLABSIs) remain a significant medical problem for critically ill cancer patients who required catheters for extended durations. Minocycline (M) -Rifampin (R) loaded catheters have shown the greatest impact on reducing CLABSIs; however, there is a risk for developing antibiotic resistant organisms when exposed to catheters whose concentration becomes depleted below antimicrobially effective levels due to extended indwells. Chlorhexidine (CH) and M-R combination catheters (MRCH) have been proposed as a next generation catheter with improved performance. Here we studied whether bacteria that were Tetracycline and Rifampin resistant became resistant to MRCH when allowed to form biofilms on MRCH catheters depleted below antimicrobially effective MRCH concentrations. Methods Minimum inhibitory concentrations (MICs) of Tetracycline and/or Rifampin resistant stock isolates were measured by standard microbroth dilution methods. MRCH catheters were depleted to below antimicrobially effective concentrations by soaking in serum for 6 weeks. The resistant bacteria were then allowed to form biofilm for 24 hrs on the depleted catheters in broth. Following 24 hour incubation the adherent (breakthrough) bacteria were removed by sonication and MICs were remeasured. The same organisms grown on non-antimicrobial catheters were used as controls. Results MICs (ug/mL) of the organisms against each agent and the combination are tabulated below: MICs (ug/mL) of the organisms against each agent and the combination Conclusion The M and R resistant bacteria did not develop in vitro resistance to the MRCH combination after forming biofilms on MRCH catheters depleted below antimicrobially effective concentrations. Disclosures Joel Rosenblatt, PhD, Cook Medical (Shareholder, Other Financial or Material Support, Inventor of the MRCH catheter technology which is owned by the University of Texas MD Anderson Cancer Center and has been licensed to Cook Medical)Novel Anti-Infective Technologies (Shareholder, Other Financial or Material Support, Inventor of the MRCH catheter technology which is owned by the University of Texas MD Anderson Cancer Center and has been licensed to Cook Medical) Issam I. Raad, MD, Citius (Other Financial or Material Support, Ownership interest)Cook Medical (Grant/Research Support)Inventive Protocol (Other Financial or Material Support, Ownership interest)Novel Anti-Infective Technologies (Shareholder, Other Financial or Material Support, Ownership interest)


2022 ◽  
Author(s):  
Mark Sheehan ◽  
Kristopher Coppin ◽  
Cormac O’ Brien ◽  
Andrew McGrath ◽  
Mark Given ◽  
...  

Abstract Background:To evaluate Inferior vena cava (IVC) filter retrieval practices over a 9-year period at an academic hospital with a prospectively maintained IVC filter registry. Method:An IVC filter registry was maintained prospectively within our institution. We reviewed cases between August 2011 and June 2020, following filter status, retrieval plans, and eventual retrieval date. The validity of the database was cross referenced with a Picture Archiving and Communication System and patient records. Results:343 patients had IVC filters inserted. Three filter types were used, Celect (Cook Medical) in 189, Gunther Tulip (GT) (Cook Medical) in 65, ALN (ALN) in 89. 196 filters were retrieved, 108 were made permanent, 36 died before retrieval, and 3 were yet to be retrieved. Retrieval rates were 92.5% overall (86% for GT, 93% for Celect and 94.5% for ALN). The mean dwell time for successful retrieval was 59 days with the majority of insertions (85%) removed in under 100 days. Failed initial retrieval occurred in 23 patients, 10 (43%) were retrieved at second attempt, 13/23 filters remained in-situ and were deemed permanent after discussion with the patient and referring team. Conclusion:The removal of IVC filters, when indication for insertion has past, is no longer the sole responsibility of the referring physician but also the responsibility of the Interventionalist. Our retrieval rates of 92.5% of eligible IVC filters highlights the value of maintaining a prospective IVC filter registry.


Sign in / Sign up

Export Citation Format

Share Document